GSK is a global biopharma company uniting science, technology and talent to get ahead of diseases together. They focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas.
LAMT medical strategy activities across current LAI assets and future pipeline programs.
Contribution to global medical projects supporting long‑acting HIV treatment and prevention.
Support for evidence‑focused activities, including literature reviews, data synthesis, and interpretation of clinical, real‑world, or modeling outputs relevant to LAI assets.